Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis

Oral Diseases

Volumn 17, Issue 1, 2011, Pages 68-76

  Ozcaka O ^a   Bicakci N ^a   Pussinen, P ^b   Sorsa, T ^b   Kose T ^a   Buduneli, N ^a  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Chronic periodontitis; MMP 8; MMP 9; Myeloperoxidase; Neutrophil elastase; Serum; Smoking; TIMP 1

Indexed keywords

GELATINASE B; LEUKOCYTE ELASTASE; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CHRONIC PERIODONTITIS; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; FEMALE; HUMANS; LEUKOCYTE ELASTASE; MALE; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PEROXIDASE; REFERENCE VALUES; SMOKING; STATISTICS, NONPARAMETRIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 78650085459     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01705.x     Document Type: Article

References (46)

1. Ah MK, Johnson GK, Kaldahl WB, Patil KD, Kalkwarf KL (1994). The effect of smoking on the response to periodontal therapy. J Clin Periodontol 21: 91-97.
2. Aiba T, Akeno N, Kawane T, Okamoto H, Horiuchi N (1996). Matrix metalloproteinases-1 and -8 and TIMP-1 mRNA levels in normal and diseased human gingivae. Eur J Oral Sci 104: 562-569.
3. Andelid K, Bake B, Rak S, Lindén A, Rosengren A, Ekberg-Jansson A (2007). Myeloperoxidase as a marker of increasing systemic inflammation in smokers without severe airway symptoms. Respir Med 101: 888-895.
4. Arbes SJ Jr, Slade GD, Beck JD (1999). Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III data. J Dent Res 78: 1777-1782.
5. Armitage GC (1999). Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4: 1-6.
6. Behle JH, Sedaghatfar MH, Demmer RT, et al. (2009). Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol 36: 287-294.
7. Bergstrom J, Eliasson S, Dock J (2000). Exposure to tobacco smoking and periodontal health. J Clin Periodontol 27: 61-68.
8. Betsuyaku T, Nishimura M, Takeyabu K, et al. (1999). Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 159: 1985-1991.
9. Biyikoǧlu B, Buduneli N, Kardeşler L, Aksu K, Pitkala M, Sorsa T (2009). Gingival crevicular fluid matrix metalloproteinase-8, -13 and tissue inhibitor of matrix metalloproteinase-1 levels in rheumatoid arthritis patients with inflammatory periodontal disease. J Periodontol 80: 1307-1316.
10. Boström L, Linder LE, Bergström J (1999). Smoking and crevicular fluid levels of IL-6 and TNF-alpha in periodontal disease. J Clin Periodontol 26: 352-357.
11. Buchmann R, Hasilik A, Nunn ME, Van Dyke TE, Lange DE (2002). PMN responses in chronic periodontal disease: evaluation by gingival crevicular fluid enzymes and elastase-alpha-1-proteinase inhibitor complex. J Clin Periodontol 29: 563-572.
12. Buduneli N, Vardar S, Atilla G, Sorsa T, Luoto H, Baylas H (2002). Ginvival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy. J Periodontol 73: 103-109.
13. Buduneli N, Kardeşler L, Işik H, et al. (2006). Effects of smoking and gingival inflammation on salivary antioxidant capacity. J Clin Periodontol 33: 159-164.
14. Buduneli E, Vardar-Şengül S, Buduneli N, Atilla G, Wahlgren J, Sorsa T (2007). Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 γ2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate. J Periodontol 78: 127-134.
15. Calsina G, Ramón JM, Echeverría JJ (2002). Effects of smoking on periodontal tissues. J Clin Periodontol 29: 771-776.
16. Cole AA, Chubinskaya S, Schumacher B, et al. (1996). Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J Biol Chem 271: 11023-11026.
17. Geraghty P, Rogan MP, Greene CM, et al. (2007). Neutrophil elastase up-regulates cathepsin B and matrix metalloproteinase-2 expression. J Immunol 178: 5871-5878.
18. Golub LM, Lee HM, Stoner JA, et al. (2008). Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women. J Periodontol 79: 1409-1418.
19. Grossi SG, Genco RJ, Machtei EE, et al. (1995). Assessment of risk for periodontal disease II. Risk indicators for alveolar bone loss. J Periodontol 66: 23-29.
20. Hanemaaijer R, Sorsa T, Konttinen YT, et al. (1997). Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 273: 1504-1509.
21. Howard EW, Bullen EC, Banda MJ (1991). Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinasees-2. J Biol Chem 266: 13070-13075.
22. Kawabata K, Hagio T, Matsuoka S (2002). The role of neutrophil elastase in acute lung injury. Eur J Pharmacol 451: 1-10.
23. Knuutinen A, Kokkonen N, Risteli J, et al. (2002). Smoking affects collagen synthesis and extracellular matrix turnover in human skin. Br J Dermatol 146: 588-594.
24. Kuula H, Salo T, Pirilä E, et al. (2009). Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis. Infect Immun 77: 850-859.
25. Liede KE, Haukka JK, Hietanen JH, Mattila MH, Ronka H, Sorsa T (1999). The association between smoking cessation and periodontal status and salivary proteinase levels. J Periodontol 70: 1361-1368.
26. Liu KZ, Hynes A, Man A, Alsagheer A, Singer DL, Scott DA (2006). Increased local matrix metalloproteinase-8 expression in the periodontal connective tissues of smokers with periodontal disease. Biochim Biophys Acta 1762: 775-780.
27. Marcaccini AM, Novaes AB Jr, Meschiari CA, et al. (2009). Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy. Clin Chim Acta 409: 117-122.
28. Mullally BH (2004). The influence of tobacco smoking on the onset of periodontitis in young persons. Tob Induc Dis 2: 53-65.
29. Nicholls SJ, Hazen SL (2005). Myeloperoxidase and cardiovascular disease. Arterioscl Throm Vas 25: 1102-1111.
30. Persson L, Bergstrom J, Gustafsson A (2003). Effect of tobacco smoking on neutrophil activity following periodontal surgery. J Periodontol 74: 1475-1482.
31. Pussinen PJ, Paju S, Mäntylä P, Sorsa T (2007). Serum microbial- and host-derived markers of periodontal diseases: a review. Curr Med Chem 14: 2402-2412.
32. Rautelin HI, Oksanen AM, Veijola LI, et al. (2009). nhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis. Ann Med 41: 208-215.
33. Rawlinson A, Grummitt JM, Walsh TF, Ian Douglas CW (2003). Interleukin-1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers. J Clin Periodontol 30: 42-48.
34. Renvert S, Dahlén G, Wikström M (1998). The clinical and microbiological effects of non-surgical periodontal therapy in smokers and non-smokers. J Clin Periodontol 25: 153-157.
35. Said S, Mohd H, Sander L, Ronka H, Sorsa T, Kinane DF (1999). GCF levels of MMP-3 and MMP-8 following placement of bioresorbable membranes. J Clin Periodontol 26: 757-763.
36. Soder B, Jin LJ, Wickholm S (2002). Granulocyte elastase, matrix metalloproteinase-8 and prostaglandin E2 in gingival crevicular fluid in matched clinical sites in smokers and non-smokers with persistent periodontitis. J Clin Periodontol 29: 384-391.
37. Sorsa T, Mäntylä P, Rönkä H, et al. (1999). Scientific basis of matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann N.Y. Acad Sci 878: 130-140.
38. Sorsa T, Tjaderhane L, Salo T (2004). Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 10: 311-318.
39. Sorsa T, Tjaderhane L, Konttinen YT, et al. (2006). Matrix metalloproteinases: contribution to pathogenesis and treatment of periodontal inflammation. Ann Med 38: 306-321.
40. Tonetti MS (1998). Cigarette smoking and periodontal diseases: etiology and management of disease. Ann Periodontol 3: 88-101.
41. Tuomainen AM, Nyyssonen K, Laukkanen JA, et al. (2007). Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vasc Biol 27: 2722-2728.
42. Ujiie Y, Oida S, Gomi K, Arai T, Fukae M (2007). Neutrophil elastase is involved in the initial destruction of human periodontal ligament. J Periodontal Res 42: 325-330.
43. Vardar-Şengül S, Buduneli E, Türkoǧlu O, et al. (2008). The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5γ2 chain immunolocalization in experimental periodontitis. J Periodontol 79: 1934-1941.
44. Wei PF, Ho KY, Ho YP, Wu YM, Yang YH, Tsai CC (2004). The investigation of glutathione peroxidase, lactoferrin, myeloperoxidase and interleukin-1beta in gingival crevicular fluid: Implications for oxidative stress in human periodontal diseases. J Periodontal Res 39: 287-293.
45. Wohlfeil M, Wehner J, Schacher B, Oremek GM, Sauer-Eppel H, Eickholz P (2009). Degree of gingivitis correlates to systemic inflammation markers. Clin Chimi Acta 401: 105-109.
46. Yamalik N, Çaǧlayan F, Kilinç K, Kilinç A, Tümer C (2000). The importance of data presentation regarding gingival crevicular fluid myeloperoxidase and elastase like activity in periodontal disease and health status. J Periodontol 71: 460-467.